Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aytu BioPharma Inc.

    NASDAQ: AYTU · Real-Time Price · USD
    1.99
    0.04 (2.05%)
    At close: Jun 16, 2025, 3:59 PM
    1.98
    -0.52%
    Pre-market: Jun 17, 2025, 08:00 AM EDT

    Aytu BioPharma Statistics

    Share Statistics

    Aytu BioPharma has 6.17M shares outstanding. The number of shares has increased by 3.31% in one year.

    Shares Outstanding

    n/a
    		 6.17M

    Shares Change (YoY)

    n/a
    		 3.31%

    Shares Change (QoQ)

    n/a
    		 0.33%

    Owned by Institutions (%)

    n/a
    		 30.67%

    Shares Floating

    n/a
    		 5.99M

    Failed to Deliver (FTD) Shares

    n/a
    		 298

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 416.69K, so 6.75% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 416.69K

    Short % of Shares Out

    n/a
    		 6.75%

    Short % of Float

    n/a
    		 9.73%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1 and the forward PE ratio is 1.45. Aytu BioPharma's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1

    Forward PE

    n/a
    		 1.45

    PS Ratio

    n/a
    		 0.19

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.57

    P/FCF Ratio

    n/a
    		 -11.37

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aytu BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.55.

    Current Ratio

    n/a
    		 0.99

    Quick Ratio

    n/a
    		 0.79

    Debt / Equity

    n/a
    		 0.55

    Debt / EBITDA

    n/a
    		 -14.95

    Debt / FCF

    n/a
    		 -10.9

    Interest Coverage

    n/a
    		 -1.1

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $794,137.25

    Profits Per Employee

    n/a
    		 $-155,333.33

    Employee Count

    n/a
    		 102

    Asset Turnover

    n/a
    		 0.69

    Inventory Turnover

    n/a
    		 2.09

    Taxes

    Income Tax

    n/a
    		 1.77M

    Effective Tax Rate

    n/a
    		 -12.56%

    Stock Price Statistics

    The stock price has increased by -29.18% in the last 52 weeks. The beta is 0.05, so Aytu BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.05

    52-Week Price Change

    n/a
    		 -29.18%

    50-Day Moving Average

    n/a
    		 1.49

    200-Day Moving Average

    n/a
    		 1.69

    Relative Strength Index (RSI)

    n/a
    		 57.89

    Average Volume (20 Days)

    n/a
    		 1,365,719

    Income Statement

    In the last 12 months, Aytu BioPharma had revenue of 81M and earned -15.84M in profits. Earnings per share was -2.86.

    Revenue

    n/a
    		 81M

    Gross Profit

    n/a
    		 54.59M

    Operating Income

    n/a
    		 -5.25M

    Net Income

    n/a
    		 -15.84M

    EBITDA

    n/a
    		 -1.01M

    EBIT

    n/a
    		 -9.28M

    Earnings Per Share (EPS)

    n/a
    		 -2.86
    Full Income Statement

    Balance Sheet

    The company has 20.01M in cash and 15.13M in debt, giving a net cash position of 4.88M.

    Cash & Cash Equivalents

    n/a
    		 20.01M

    Total Debt

    n/a
    		 15.13M

    Net Cash

    n/a
    		 4.88M

    Retained Earnings

    n/a
    		 -319.97M

    Total Assets

    n/a
    		 124.2M

    Working Capital

    n/a
    		 1.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.39M and capital expenditures 0, giving a free cash flow of -1.39M.

    Operating Cash Flow

    n/a
    		 -1.39M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -1.39M

    FCF Per Share

    n/a
    		 -0.25
    Full Cash Flow Statement

    Margins

    Gross margin is 67.39%, with operating and profit margins of -6.49% and -19.56%.

    Gross Margin

    n/a
    		 67.39%

    Operating Margin

    n/a
    		 -6.49%

    Pretax Margin

    n/a
    		 -17.38%

    Profit Margin

    n/a
    		 -19.56%

    EBITDA Margin

    n/a
    		 -1.25%

    EBIT Margin

    n/a
    		 -6.49%

    FCF Margin

    n/a
    		 -1.71%

    Dividends & Yields

    AYTU does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AYTU.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 6, 2023. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jan 6, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -2.92

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist